Equities analysts predict that PetIQ Inc (NASDAQ:PETQ) will report $0.28 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for PetIQ’s earnings, with the highest EPS estimate coming in at $0.29 and the lowest estimate coming in at $0.27. PetIQ posted earnings per share of $0.66 during the same quarter last year, which would suggest a negative year-over-year growth rate of 57.6%. The company is expected to announce its next quarterly earnings report after the market closes on Wednesday, August 7th.
According to Zacks, analysts expect that PetIQ will report full-year earnings of $0.81 per share for the current year. For the next year, analysts anticipate that the firm will report earnings of $0.97 per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that cover PetIQ.
PetIQ (NASDAQ:PETQ) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.27 EPS for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.19. The business had revenue of $148.44 million for the quarter, compared to analyst estimates of $139.03 million. PetIQ had a net margin of 0.51% and a return on equity of 9.47%.
In other PetIQ news, insider Will Santana sold 20,000 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $27.85, for a total transaction of $557,000.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director James Nathan Clarke purchased 31,031 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were purchased at an average cost of $28.12 per share, for a total transaction of $872,591.72. The disclosure for this purchase can be found here. Insiders have sold 120,291 shares of company stock worth $3,575,091 over the last ninety days. Insiders own 23.79% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Manchester Capital Management LLC bought a new stake in PetIQ during the first quarter worth $30,000. FNY Investment Advisers LLC bought a new stake in PetIQ during the first quarter worth $56,000. Citigroup Inc. raised its position in PetIQ by 43.5% during the fourth quarter. Citigroup Inc. now owns 1,827 shares of the company’s stock worth $43,000 after acquiring an additional 554 shares in the last quarter. Legal & General Group Plc raised its position in PetIQ by 42.6% during the fourth quarter. Legal & General Group Plc now owns 2,451 shares of the company’s stock worth $58,000 after acquiring an additional 732 shares in the last quarter. Finally, BNP Paribas Arbitrage SA raised its position in PetIQ by 327,900.0% during the first quarter. BNP Paribas Arbitrage SA now owns 3,280 shares of the company’s stock worth $103,000 after acquiring an additional 3,279 shares in the last quarter. 91.47% of the stock is currently owned by hedge funds and other institutional investors.
Shares of PETQ stock traded up $0.48 during trading on Monday, reaching $36.00. The company’s stock had a trading volume of 222,549 shares, compared to its average volume of 329,752. The firm’s fifty day moving average is $31.56. The company has a current ratio of 2.89, a quick ratio of 1.51 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $1.00 billion, a P/E ratio of 28.80, a price-to-earnings-growth ratio of 1.92 and a beta of 2.06. PetIQ has a one year low of $21.29 and a one year high of $43.93.
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.
Read More: Diluted Earnings Per Share
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.